Vaccines

Executive Summary

This section describes market access for vaccines in France. We highlight key decision makers such as CEPS, CT, CTV and HAS. We also explain marketing authorisation considerations, and issues around pricing and reimbursement, to help you navigate this bespoke part of the French health system.